These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 3455064

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Changes in bone histology after treatment with desferrioxamine.
    Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ.
    Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Long term CaCO3 treatment of chronic hemodialysis patients--an attempt to prevent and treat aluminum osteopathy].
    Matsubara M, Totsune K, Saito T, Yoshinaga K, Unagami H, Sato H.
    Nihon Jinzo Gakkai Shi; 1988 Nov; 30(11):1349-54. PubMed ID: 3236516
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum].
    Gordillo-Paniagua G, Valencia-Mayoral P, Mercado L, Medina-Mercado M.
    Bol Med Hosp Infant Mex; 1990 May; 47(5):336-41. PubMed ID: 2390188
    [Abstract] [Full Text] [Related]

  • 11. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
    Faugere MC, Arnala IO, Ritz E, Malluche HH.
    J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929
    [Abstract] [Full Text] [Related]

  • 12. Effect of aluminum on bone and cell localization.
    Cournot-Witmer G, Plachot JJ, Bourdeau A, Lieberherr M, Jorgetti V, Mendes V, Halpern S, Hemmerle J, Drüeke T, Balsan S.
    Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Idiopathic hypercalcaemia of chronic dialysis.
    Feest TG, Newrick P, Read DJ.
    Proc Eur Dial Transplant Assoc; 1983 Feb; 19():248-52. PubMed ID: 6348738
    [Abstract] [Full Text] [Related]

  • 17. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK, Lu HB, Chan CY, Cheng SW, Robinson JD, Tam SC, Lo WK, Cheung WC.
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralization.
    Costantini S, Bonucci E, Mocetti P, Ballanti P, Giordano R, Vernillo I, Ioppolo A, Mantovani A, Stasolla D.
    Ann Ist Super Sanita; 1986 Aug; 22(2):689-95. PubMed ID: 3752831
    [No Abstract] [Full Text] [Related]

  • 20. Deferoxamine and aluminum removal.
    Swartz RD.
    Am J Kidney Dis; 1985 Nov; 6(5):358-64. PubMed ID: 3904429
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.